Replies to post #495067 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

pcguy..... Missling is preparing for the future. Immediately after approval (4 to 83%) the company will have to make some significant choice on how to proceed.

It can partner.
It can sign marketing deals.
It can go it alone for the EU.

Each of those choices has very different effects on the shareholders and has different capital requirements.

Having sufficient access to capital assured increases the negotiating strength of the company and allow for going it alone if that is what looks to be the best choice
for shareholders. Without having visible access to large amounts of capital the power balance in negotiating shifts away from the company to the other party.

The pearl clutching over the prospectus is considerably overblown in my view. I see it as a strategic move on the company's part.

[Bourbon_on_my_cornflakes]

Let me ask, when it the "right" time to tap the ATM?

When epic 371 Schizo results drive the stock over $40 a share.